Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome, May 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 95 articles:
HTML format


 

Single Articles

  1. IRIBARREN C, Nordlander S, Sundin J, Isaksson S, et al
    Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids.
    Neurogastroenterol Motil. 2022 Apr 29:e14390. doi: 10.1111/nmo.14390.
    PubMed    
    Abstract available

  2. NILHOLM C, Manoharan L, Roth B, D'Amato M, et al
    A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA level
    United European Gastroenterol J. 2022 Apr 28. doi: 10.1002/ueg2.12227.
    PubMed    
    Abstract available

  3. EDWINSON AL, Yang L, Peters S, Hanning N, et al
    Gut microbial beta-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome.
    Nat Microbiol. 2022 Apr 28. pii: 10.1038/s41564-022-01103.
    PubMed    
    Abstract available

  4. LAI Y, Liang X, Fan H, Liu Y, et al
    Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: a randomized controlled trial.
    Complement Ther Med. 2022 Apr 25:102839. doi: 10.1016/j.ctim.2022.102839.
    PubMed    
    Abstract available

  5. COOK TM, Mansuy-Aubert V
    Communication between the gut microbiota and peripheral nervous system in health and chronic disease.
    Gut Microbes. 2022;14:2068365.
    PubMed    
    Abstract available

  6. TRIESCHMANN K, Chang L, Park S, Naliboff B, et al
    The visceral sensitivity index: A novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease.
    Neurogastroenterol Motil. 2022 Apr 27:e14384. doi: 10.1111/nmo.14384.
    PubMed    
    Abstract available

  7. SANDERS AE, Weatherspoon ED, Ehrmann BM, Soma PS, et al
    Ratio of omega-6/omega-3 polyunsaturated fatty acids associated with somatic and depressive symptoms in people with painful temporomandibular disorder and irritable bowel syndrome.
    J Pain. 2022 Apr 24. pii: S1526-5900(22)00304.
    PubMed    
    Abstract available

  8. WILHELM-ROMERO K, Quiros-Fallas MI, Vega-Baudrit JR, Guillen-Giron T, et al
    Evaluation of Piperine as Natural Coformer for Eutectics Preparation of Drugs Used in the Treatment of Cardiovascular Diseases.
    AAPS PharmSciTech. 2022;23:127.
    PubMed    
    Abstract available

  9. BIELECKA U, Schier K, Hardt J
    Own body experience and parents' attitudes perceived retrospectively in patients with irritable bowel syndrome.
    Psychiatr Pol. 2021;55:1405-1420.
    PubMed    
    Abstract available

  10. NAITOU K, Iwashita H, Ueda HH, Shiraishi M, et al
    Intrathecally administered substance P activated the spinal defecation center and enhanced colorectal motility in anesthetized rats.
    Am J Physiol Gastrointest Liver Physiol. 2022.
    PubMed    
    Abstract available

  11. PERUHOVA M, Mihova A, Altankova I, Velikova T, et al
    Specific Immunoglobulin E and G to Common Food Antigens and Increased Serum Zonulin in IBS Patients: A Single-Center Bulgarian Study.
    Antibodies (Basel). 2022;11.
    PubMed    
    Abstract available

  12. PARVEEN S, Imran Afridi H, Gul Kazi T, Talpur FN, et al
    Impacts of Smoking and Stomach Disorders on Essential Elements in Biological Samples of Cement and Glass Industrial Workers.
    Biol Trace Elem Res. 2022 Apr 23. pii: 10.1007/s12011-022-03238.
    PubMed    
    Abstract available

  13. REXWINKEL R, Vlieger AM, Saps M, Tabbers MM, et al
    A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified.
    Eur J Pediatr. 2022 Apr 23. pii: 10.1007/s00431-022-04459.
    PubMed    
    Abstract available

  14. YUK JS, Kim JM
    Uterine fibroids increase the risk of thyroid goiter and thyroid nodules.
    Sci Rep. 2022;12:6620.
    PubMed    
    Abstract available

  15. BALMUS IM, Copolovici D, Copolovici L, Ciobica A, et al
    Biomolecules from Plant Wastes Potentially Relevant in the Management of Irritable Bowel Syndrome and Co-Occurring Symptomatology.
    Molecules. 2022;27.
    PubMed    
    Abstract available

  16. RUSSO F, Riezzo G, Orlando A, Linsalata M, et al
    A Comparison of the Low-FODMAPs Diet and a Tritordeum-Based Diet on the Gastrointestinal Symptom Profile of Patients Suffering from Irritable Bowel Syndrome-Diarrhea Variant (IBS-D): A Randomized Controlled Trial.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  17. KASTI A, Petsis K, Lambrinou S, Katsas K, et al
    A Combination of Mediterranean and Low-FODMAP Diets for Managing IBS Symptoms? Ask Your Gut!
    Microorganisms. 2022;10.
    PubMed    
    Abstract available

  18. ROMBOLA L, Straface M, Scuteri D, Sakurada T, et al
    Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues.
    Pharmaceutics. 2022;14.
    PubMed    
    Abstract available

  19. LEE DY, Kang HE
    Pharmacokinetics of DA-6886, A New 5-HT4 Receptor Agonist, in Rats.
    Pharmaceutics. 2022;14.
    PubMed    
    Abstract available

  20. BARBOI OB, Chirila I, Ciortescu I, Anton C, et al
    Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with Constipation-Randomized Case-Control Study.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  21. STEPAN MD, Cioboata R, Vintilescu SB, Vasile CM, et al
    Pediatric Functional Abdominal Pain Disorders following COVID-19.
    Life (Basel). 2022;12.
    PubMed    
    Abstract available

  22. LIU L, Zhang W, Zhao W, Guo S, et al
    Linaclotide for treating patients with irritable bowel syndrome with predominant constipation: a multicentre study of real-world data in China.
    Therap Adv Gastroenterol. 2022;15:17562848221092596.
    PubMed    
    Abstract available

  23. LIN L, Wang T, Lu Y, Chen P, et al
    Mucosal healing and quality of life in therapeutic goals of ulcerative colitis: occurrence and related factors of functional bowel disorder-like symptoms.
    Therap Adv Gastroenterol. 2022;15:17562848221092597.
    PubMed    
    Abstract available

  24. HUANG H, Lu L, Chen Y, Zeng Y, et al
    The efficacy of vitamin D supplementation for irritable bowel syndrome: a systematic review with meta-analysis.
    Nutr J. 2022;21:24.
    PubMed    
    Abstract available

  25. CAMILLERI M, Magnus Y, Carlson P, Wang XJ, et al
    Differential mRNA Expression in Ileal and Colonic Biopsies in Irritable Bowel Syndrome with Diarrhea or Constipation.
    Am J Physiol Gastrointest Liver Physiol. 2022.
    PubMed    
    Abstract available

  26. LIU D, Ruan M, Tong C, Huang R, et al
    Effect of Shugan Jianpi Recipe Combined with Cross Moxibustion on Biochemical Examination Indexes and Total Score of TCM Symptoms in Patients with Spleen-Stomach Damp-Heat Diarrhea Irritable Bowel Syndrome.
    Comput Math Methods Med. 2022;2022:8286146.
    PubMed    
    Abstract available


  27. Findings from a survey about hidradenitis suppurativa in the Netherlands.
    Br J Dermatol. 2022;186:e200-e219.
    PubMed    
    Abstract available

  28. GONCALVES S, Nunes-Costa D, Cardoso SM, Empadinhas N, et al
    Enzyme Promiscuity in Serotonin Biosynthesis, From Bacteria to Plants and Humans.
    Front Microbiol. 2022;13:873555.
    PubMed    
    Abstract available

  29. LI M, Wang C, Guo Q, Xu C, et al
    More Positive or More Negative? Metagenomic Analysis Reveals Roles of Virome in Human Disease-Related Gut Microbiome.
    Front Cell Infect Microbiol. 2022;12:846063.
    PubMed    
    Abstract available

  30. YANG W, Yang X, Cai X, Zhou Z, et al
    The Prevalence of Irritable Bowel Syndrome Among Chinese University Students: A Systematic Review and Meta-Analysis.
    Front Public Health. 2022;10:864721.
    PubMed    
    Abstract available

  31. SHUKLA R, Pahal S, Gupta A, Choudhary P, et al
    Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer's and Parkinson's diseases as druggable targets through Withania somnifera bioactives: an in silico study.
    J Biomol Struct Dyn. 2022 May 1:1-19. doi: 10.1080/07391102.2022.2068072.
    PubMed    
    Abstract available

  32. ISMAIL MH, Molan AL, Abbas SK
    Serological levels of cytokines in irritable bowel syndrome (IBS) patients and non-IBS subjects with and without Blastocystis spp. infection.
    Ann Parasitol. 2022;68:77-85.
    PubMed    
    Abstract available

  33. BACKRYD E
    [Navigating between opiophobia and opiocentrism in today's healthcare].
    Lakartidningen. 2022;119.
    PubMed    
    Abstract available

  34. MOBEEN A, Moazzam SW
    Jawarish Shahi: A special dosage form of herbal formulations for functional gastrointestinal disorders in Unani medicine- A comprehensive review.
    J Ethnopharmacol. 2022;293:115319.
    PubMed    
    Abstract available

  35. WEI LJ, Hou Q, Yao NN, Liang Y, et al
    [Construction of a nomogram model for predicting 2-year survival rate of small cell lung cancer based on more comprehensive variables].
    Zhonghua Yi Xue Za Zhi. 2022;102:1283-1289.
    PubMed    
    Abstract available

  36. XIAO D, Zhang Y, Chen W, Xuan J, et al
    Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China.
    Adv Ther. 2022 Apr 30. pii: 10.1007/s12325-022-02161.
    PubMed    
    Abstract available

  37. RESTREPO-PINEDA S, Sanchez-Puig N, Perez NO, Garcia-Hernandez E, et al
    The pre-induction temperature affects recombinant HuGM-CSF aggregation in thermoinducible Escherichia coli.
    Appl Microbiol Biotechnol. 2022;106:2883-2902.
    PubMed    
    Abstract available

  38. HAUSER W, Andresen V
    [Functional gastrointestinal disorders].
    Dtsch Med Wochenschr. 2022;147:595-604.
    PubMed    
    Abstract available

  39. COFFMAN CN, Varga MG, Alcock J, Carrol-Portillo A, et al
    Norepinephrine induces growth of Desulfovibrio vulgaris in an iron dependent manner.
    Anaerobe. 2022 May 6:102582. doi: 10.1016/j.anaerobe.2022.102582.
    PubMed    
    Abstract available

  40. BLACK CJ, Houghton LA, Ford AC
    Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.
    Neurogastroenterol Motil. 2022 May 9:e14391. doi: 10.1111/nmo.14391.
    PubMed    
    Abstract available

  41. JI S, Zhang Q
    Momordica charantia polysaccharides alleviate diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and barrier via NF-kappaB pathway.
    Allergol Immunopathol (Madr). 2022;50:62-70.
    PubMed    
    Abstract available

  42. NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
    Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model.
    Neuropeptides. 2022;94:102248.
    PubMed    
    Abstract available

  43. RAY K
    Regulating protease homeostasis in irritable bowel syndrome.
    Nat Rev Gastroenterol Hepatol. 2022 May 6. pii: 10.1038/s41575-022-00629.
    PubMed    


  44. JI NN, Meng QX, Wang Y, Zhou ZM, et al
    Microglia-derived TNF-alpha inhibiting GABAergic neurons in the anterior lateral bed nucleus of the stria terminalis precipitates visceral hypersensitivity induced by colorectal distension in rats.
    Neurobiol Stress. 2022;18:100449.
    PubMed    
    Abstract available

  45. WURTZ F, Zahler L, Blackwell SE, Margraf J, et al
    Scrambled but valid? The scrambled sentences task as a measure of interpretation biases in psychopathology: A systematic review and meta-analysis.
    Clin Psychol Rev. 2022;93:102133.
    PubMed    
    Abstract available

  46. OHLSSON B
    Functional bowel symptoms in the general population (Review).
    Mol Med Rep. 2022;26.
    PubMed    
    Abstract available

  47. ALSMADI MM, Al-Daoud NM, Obaidat RM, Abu-Farsakh NA, et al
    Enhancing Atorvastatin In Vivo Oral Bioavailability in the Presence of Inflammatory Bowel Disease and Irritable Bowel Syndrome Using Supercritical Fluid Technology Guided by wbPBPK Modeling in Rat and Human.
    AAPS PharmSciTech. 2022;23:148.
    PubMed    
    Abstract available

  48. CHANG WY, Yang YT, She MP, Tu CH, et al
    5-HT7 receptor-dependent intestinal neurite outgrowth contributes to visceral hypersensitivity in irritable bowel syndrome.
    Lab Invest. 2022 May 18. pii: 10.1038/s41374-022-00800.
    PubMed    
    Abstract available

  49. UHLENBUSCH N, Manthey C, Nestoriuc Y, Andresen V, et al
    [Psychosocial Support for People with Ulcerative Colitis and Irritable Bowel Syndrome: A Feasibility Study on Need, Focus and Viability].
    Psychother Psychosom Med Psychol. 2022 May 18. doi: 10.1055/a-1785-5496.
    PubMed    
    Abstract available

  50. LUO M, Liu Q, Xiao L, Xiong LS, et al
    Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation.
    J Health Popul Nutr. 2022;41:21.
    PubMed    
    Abstract available

  51. PRIYA S, Burns MB, Ward T, Mars RAT, et al
    Identification of shared and disease-specific host gene-microbiome associations across human diseases using multi-omic integration.
    Nat Microbiol. 2022 May 16. pii: 10.1038/s41564-022-01121.
    PubMed    
    Abstract available

  52. RIJNAARTS I, de Roos NM, Wang T, Zoetendal EG, et al
    A high-fibre personalised dietary advice given via a web tool reduces constipation complaints in adults.
    J Nutr Sci. 2022;11:e31.
    PubMed    
    Abstract available

  53. YU Z, Liu LY, Lai YY, Tian ZL, et al
    Altered Resting Brain Functions in Patients With Irritable Bowel Syndrome: A Systematic Review.
    Front Hum Neurosci. 2022;16:851586.
    PubMed    
    Abstract available

  54. DE GRAAF MCG, Spooren CEGM, Hendrix EMB, Hesselink MAM, et al
    Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  55. FERNANDEZ-BANARES F
    Carbohydrate Maldigestion and Intolerance.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  56. PLAIDUM S, Patcharatrakul T, Promjampa W, Gonlachanvit S, et al
    The Effect of Fermentable, Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Meals on Transient Lower Esophageal Relaxations (TLESR) in Gastroesophageal Reflux Disease (GERD) Patients with Overlapping Irritable Bowel Syndrome (IBS
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  57. ZAWISTOWSKA-ROJEK A, Tyski S
    How to Improve Health with Biological Agents-Narrative Review.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  58. ROTH B, Myllyvainio J, D'Amato M, Larsson E, et al
    A Starch- and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin: A Randomized Controlled Study.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  59. MAHMOOD A, Iqbal J
    Purinergic receptors modulators: An emerging pharmacological tool for disease management.
    Med Res Rev. 2022 May 13. doi: 10.1002/med.21888.
    PubMed    
    Abstract available

  60. JEONG B, Sung TS, Jeon D, Park KJ, et al
    Inhibition of TRPC4 channel activity in colonic myocytes by tricyclic antidepressants disrupts colonic motility causing constipation.
    J Cell Mol Med. 2022 May 12. doi: 10.1111/jcmm.17348.
    PubMed    
    Abstract available

  61. FRANCIS-MALAVE AM, Gonzalez SM, Pichardo C, Wilson TD, et al
    Sex differences in pain-related behaviors and clinical progression of disease in mouse models of colonic pain.
    Pain. 2022 May 13. pii: 00006396-990000000-00090.
    PubMed    
    Abstract available

  62. MIRZAIE Z, Bastani A, Haji-Aghamohammadi AA, Rashidi Nooshabadi M, et al
    Effects of Ellagic Acid on Oxidative Stress Index, Inflammatory Markers and Quality of Life in Patients With Irritable Bowel Syndrome: Randomized Double-blind Clinical Trial.
    Clin Nutr Res. 2022;11:98-109.
    PubMed    
    Abstract available

  63. CEULEMANS M, Jacobs I, Wauters L, Vanuytsel T, et al
    Immune Activation in Functional Dyspepsia: Bystander Becoming the Suspect.
    Front Neurosci. 2022;16:831761.
    PubMed    
    Abstract available

  64. INCZEFI O, Bacsur P, Resal T, Keresztes C, et al
    The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease.
    Front Nutr. 2022;9:718710.
    PubMed    
    Abstract available

  65. BIN Y, Kang L, Lili Y
    Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: a systematic review and meta-analysis.
    Nutr Hosp. 2022 May 12. doi: 10.20960/nh.04044.
    PubMed    
    Abstract available

  66. LALOUNI M, Olen O, Bjureberg J, Bonnert M, et al
    Validation of child-adapted short scales for measuring gastrointestinal-specific avoidance and anxiety.
    Acta Paediatr. 2022 May 11. doi: 10.1111/apa.16403.
    PubMed    
    Abstract available

  67. D'SILVA A, Marshall DA, Vallance J, Nasser Y, et al
    Meditation and yoga for irritable bowel syndrome: study protocol for a randomised clinical trial (MY-IBS study).
    BMJ Open. 2022;12:e059604.
    PubMed    
    Abstract available

  68. LING X, Peng S, Zhong J, Guo L, et al
    Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome.
    Front Pharmacol. 2022;13:778032.
    PubMed    
    Abstract available

  69. OH JH, Jang YS, Kang D, Kim HS, et al
    Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Gut Liver. 2022 May 25. pii: gnl210478. doi: 10.5009/gnl210478.
    PubMed    
    Abstract available

  70. JAFARI S, Sajedi B, Jameshorani M, Salarpour F, et al
    Comparison of fluoxetine and duloxetine hydrochloride therapeutic effects on patients with constipation-predominant irritable bowel syndrome.
    Gastroenterol Hepatol Bed Bench. 2022;15:45-52.
    PubMed    
    Abstract available

  71. WUESTENBERGHS F, Baron M, Melchior C, Desprez C, et al
    Overlaps with bladder pain syndrome and irritable bowel syndrome are associated with higher symptom burden and reduced quality of life in functional dyspepsia.
    Neurogastroenterol Motil. 2022 May 24:e14414. doi: 10.1111/nmo.14414.
    PubMed    
    Abstract available

  72. SATISH KUMAR L, Pugalenthi LS, Ahmad M, Reddy S, et al
    Probiotics in Irritable Bowel Syndrome: A Review of Their Therapeutic Role.
    Cureus. 2022;14:e24240.
    PubMed    
    Abstract available

  73. SHAH A, Talley NJ, Holtmann G
    Current and Future Approaches for Diagnosing Small Intestinal Dysbiosis in Patients With Symptoms of Functional Dyspepsia.
    Front Neurosci. 2022;16:830356.
    PubMed    
    Abstract available

  74. GUAN L, Shi X, Tang Y, Yan Y, et al
    Contribution of Amygdala Histone Acetylation in Early Life Stress-Induced Visceral Hypersensitivity and Emotional Comorbidity.
    Front Neurosci. 2022;16:843396.
    PubMed    
    Abstract available

  75. GONZALEZ-DELGADO P, Muriel J, Jimenez T, Cameo JI, et al
    Food protein-induced enterocolitis syndrome in adulthood: clinical characteristics, prognosis and risk factors.
    J Allergy Clin Immunol Pract. 2022 May 19. pii: S2213-2198(22)00492.
    PubMed    
    Abstract available

  76. LOVDAHL J, Tornblom H, Ringstrom G, Palsson OS, et al
    Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022 May 3. doi: 10.1111/apt.16934.
    PubMed    
    Abstract available

  77. GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
    Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom.
    Aliment Pharmacol Ther. 2022 May 1. doi: 10.1111/apt.16939.
    PubMed    
    Abstract available

  78. GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
    Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition. Authors' reply.
    Aliment Pharmacol Ther. 2022;55:1590-1591.
    PubMed    


  79. BERINSTEIN JA, Fendrick AM
    Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition.
    Aliment Pharmacol Ther. 2022;55:1588-1589.
    PubMed    


  80. TAKAKURA W, Pimentel M, Rao S, Villanueva-Millan MJ, et al
    A Single Fasting Exhaled Methane Level Correlates With Fecal Methanogen Load, Clinical Symptoms and Accurately Detects Intestinal Methanogen Overgrowth.
    Am J Gastroenterol. 2022;117:470-477.
    PubMed    
    Abstract available

  81. VAN DEN HOUTE K, Bercik P, Simren M, Tack J, et al
    Mechanisms underlying food-triggered symptoms in disorders of gut-brain interactions.
    Am J Gastroenterol. 2022 May 4. pii: 00000434-990000000-00357.
    PubMed    
    Abstract available

  82. DULANEY DT
    Continuing Medical Education Questions: May 2022.
    Am J Gastroenterol. 2022;117:720.
    PubMed    
    Abstract available

  83. LACY BE, Cangemi DJ
    A Pragmatic Approach to the Evaluation and Treatment of Abdominal Bloating.
    Am J Gastroenterol. 2022;117:701-705.
    PubMed    


  84. BRAVO-VAZQUEZ LA, Medina-Rios I, Marquez-Gallardo LD, Reyes-Munoz J, et al
    Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review.
    Dig Dis Sci. 2022 May 4. pii: 10.1007/s10620-022-07516.
    PubMed    
    Abstract available

  85. YAO C, Li Y, Luo L, Xie F, et al
    Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China.
    Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07500.
    PubMed    
    Abstract available

  86. CHEN LJ, Kamp K, Fang A, Heitkemper MM, et al
    Delivery Methods of Cognitive Behavior Therapy for Patients With Irritable Bowel Syndrome.
    Gastroenterol Nurs. 2022 May 6. pii: 00001610-990000000-00002.
    PubMed    
    Abstract available

  87. AHUJA A
    Minority Patients With Irritable Bowel Syndrome Receive More Gastroenterology-Related Procedures Than White Counterparts: Nuances in Disparities Research.
    Gastroenterology. 2022;162:1354-1355.
    PubMed    


  88. CARBONE F, Van den Houte K, Besard L, Tack C, et al
    Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute.
    Gut. 2022 Apr 28. pii: gutjnl-2021-325821. doi: 10.1136/gutjnl-2021-325821.
    PubMed    
    Abstract available

  89. CAMILLERI M, Carlson P, BouSaba J, McKinzie S, et al
    Comparison of biochemical, microbial and mucosal mRNA expression in bile acid diarrhoea and irritable bowel syndrome with diarrhoea.
    Gut. 2022 May 17. pii: gutjnl-2022-327471. doi: 10.1136/gutjnl-2022-327471.
    PubMed    
    Abstract available

  90. ABUELAZM M, Abdelazeem B
    Vitamin D Supplementation for Irritable Bowel Syndrome: Concerns About the Meta-Analysis.
    J Gastroenterol Hepatol. 2022 May 5. doi: 10.1111/jgh.15883.
    PubMed    


  91. UNO Y
    Paradigm shift in FODMAP theory.
    J Gastroenterol Hepatol. 2022;37:954.
    PubMed    


  92. BEK S, Teo YN, Tan XH, Fan KH, et al
    Association between Irritable Bowel Syndrome and Micronutrients: A Systematic Review.
    J Gastroenterol Hepatol. 2022 May 17. doi: 10.1111/jgh.15891.
    PubMed    
    Abstract available

  93. KAMPHORST K, Vlieger AM, Oosterloo BC, Garssen J, et al
    Neonatal Antibiotics and Food Allergy are Associated with FGIDs at 4-6 years of age.
    J Pediatr Gastroenterol Nutr. 2022 Feb 24. pii: 00005176-900000000-95409.
    PubMed    
    Abstract available

  94. EL-SALHY M, Mazzawi T, Hausken T, Hatlebakk JG, et al
    The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
    Scand J Gastroenterol. 2022 Apr 29:1-10. doi: 10.1080/00365521.2022.2064725.
    PubMed    
    Abstract available

  95. HEDSTROM A, Kvarnstrom M, Lindberg G, Alsabeah S, et al
    High prevalence of gastrointestinal symptoms in patients with primary Sjogren's syndrome cannot be attributed to pancreatic exocrine insufficiency.
    Scand J Gastroenterol. 2022 Apr 24:1-7. doi: 10.1080/00365521.2022.2065888.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;